- Vetscan OptiCell now includes new parameters: CHCM and plateletcrit (PCT)
- First in-clinic analyzer to offer CHCM, previously only available in labs
- Enhances understanding of red blood cells and platelet health
- Provides faster, more accurate results at the point of care
- Uses AI and advanced imaging to analyze blood samples in minutes
- Designed to improve clinical decision-making without sending samples out
Zoetis has expanded the capabilities of its Vetscan OptiCell diagnostic platform, adding new blood analysis tools that bring more advanced testing directly into veterinary clinics.
Bringing Lab-Level Insights Into the Clinic
With this update, Vetscan OptiCell becomes the first point-of-care analyzer to offer cellular hemoglobin concentration mean (CHCM)—a measurement that was previously only available through external reference labs.
CHCM helps veterinarians better understand red blood cell health by directly measuring hemoglobin levels inside individual cells, offering more reliable insights than traditional calculated values.
Better Understanding of Blood Health
The system also adds plateletcrit (PCT), which measures the proportion of blood made up of platelets. This helps clinicians assess how well platelets are being produced or if they are being lost or destroyed.
Together, these new parameters give veterinarians a clearer picture of both red blood cell and platelet activity—especially useful when diagnosing conditions like anemia or clotting disorders.
Faster Results, Better Decisions
Vetscan OptiCell uses artificial intelligence and advanced imaging technology to analyze hundreds of thousands of cells in just minutes. This allows veterinary teams to get accurate results during the patient visit, rather than waiting for external lab reports.
The system’s cartridge-based design also simplifies workflow, reducing maintenance and minimizing the risk of contamination.
Supporting In-Clinic Diagnostics Growth
Zoetis says the update reflects its focus on delivering more powerful diagnostic tools directly to veterinarians. By expanding the number of measurable parameters, the platform aims to support faster diagnoses and more confident treatment decisions in everyday practice.
Information sourced from the company’s press release.
